Complement C3 Activity Assay

Creative Biolabs offers comprehensive complement C3 activity assay services to help researchers evaluate the central activation step of the complement system with sensitivity, flexibility, and project-specific assay design. As the convergence point of the classical, lectin, and alternative pathways, complement component C3 is one of the most informative targets for assessing complement initiation, amplification, regulation, and therapeutic modulation.

Submit Your Request Now

Download our service brochure

Inquiry

Why Measure Complement C3 Activity?

C3 is often described as the hub of the complement system because it connects upstream pathway initiation with downstream effector mechanisms. Classical pathway activation initiated by antibody-antigen complexes, lectin pathway activation triggered by carbohydrate pattern recognition, and alternative pathway activation driven by spontaneous hydrolysis or surface amplification all converge on C3 cleavage. Measuring C3 activity therefore provides a direct window into the functional state of the complement system.

For complement therapeutic development, C3 activity assays are especially valuable because many intervention strategies act either directly on C3 or indirectly influence C3 activation.
For antibody and biologics development, C3 activity assays can evaluate whether a molecule triggers complement deposition on target cells or immune complexes.
For disease research, abnormal C3 activation is associated with many immune-mediated, inflammatory, infectious, renal, hematological, neurological, and ocular disorders.
For biomaterials, nanoparticles, viral vectors, cell therapies, and delivery platforms, C3 activity assays can reveal whether a material or engineered system activates complement upon contact with serum.

Because C3 is involved in multiple layers of complement biology, no single readout is sufficient for every study. Creative Biolabs provides customized assay strategies that combine appropriate activation triggers, matrices, controls, pathway-dissection tools, and detection technologies to generate data that are meaningful for your model system.

Great Minds Choose Creative Biolabs

Partner with Us

Our Complement C3 Activity Assay Service

Creative Biolabs offers a flexible service portfolio for complement C3 activity assay projects. Our scientists can provide standard assay formats or develop customized protocols according to customer requirements. Depending on the project goal, one or multiple assay platforms may be recommended to obtain a comprehensive understanding of C3 activity.

C3 Functional Activity Test

The C3 functional activity test is designed to evaluate whether C3 in a sample can participate in complement activation and downstream biological reactions. This assay can be used to compare C3 activity among serum samples, plasma samples, purified C3 preparations, recombinant proteins, disease model specimens, and treated versus untreated experimental groups.

C3 Hemolytic Activity Assay

Creative Biolabs can develop hemolytic assay formats suitable for evaluating C3 activity, complement pathway performance, complement inhibitor effects, or C3-containing serum activity. The assay can be adapted for comparative studies, dose-response testing, inhibitor screening, and functional rescue experiments.

C3 Cleavage and Activation Assay

Monitoring C3 cleavage provides direct information on complement activation status and pathway progression. Creative Biolabs offers C3 cleavage and activation analysis using immunoassay-based, electrophoresis-based, or antibody detection-based methods.

C3b Deposition Assay

Creative Biolabs provides C3b deposition assay services using ELISA-based, fluorescence-based, flow cytometry-based, imaging-based, and cell-based detection platforms. These assays can assess how strongly a test surface or biological material activates complement, how efficiently a candidate inhibitor blocks C3b deposition, or how complement regulation affects surface opsonization.

C3 ELISA and Immunoassay-Based Activity Support

Creative Biolabs can measure C3 concentration, C3a, C3b, iC3b, C3d, C3 activation products, and related complement biomarkers to support functional interpretation.

C3 Inhibitor Validation Assay

C3 is a major target in complement therapeutic development. Creative Biolabs provides customized C3 inhibitor validation assays to evaluate candidate molecules that block C3 cleavage, C3 convertase activity, C3b deposition, amplification loop formation, or downstream effector functions.

C3 Convertase-Related Functional Assays

Creative Biolabs can provide C3 convertase-related assays to help researchers investigate the mechanisms that control C3 activation. These assays may be used to study classical/lectin pathway C3 convertase, alternative pathway C3 convertase, regulatory proteins, convertase inhibitors, autoantibodies, and complement amplification mechanisms.

Cell-Based C3 Activity Assay

Creative Biolabs can design cell-based C3 activity assays using disease-relevant cells, immune cells, endothelial cells, epithelial cells, erythrocytes, engineered cell lines, antibody-coated cells, or customer-provided cells.

Customized C3 Activity Assay Development

Creative Biolabs offers customized C3 activity assay development services for special sample types, rare species, limited sample volume, non-standard matrices, recombinant proteins, engineered variants, unusual activators, novel inhibitors, biomaterials, nanoparticles, and translational research models.

Discuss Your Needs

Available Sample Types

Creative Biolabs supports a broad range of sample types for complement C3 activity assay services. Commonly accepted sample types include:

Human/animal serum, plasma

Purified C3 protein, recombinant C3 protein or C3 variants

Cell culture supernatant, tissue homogenate, biological fluids

Disease model samples, preclinical study samples, antibody-treated samples

Service Workflow

Creative Biolabs has developed a streamlined workflow to ensure that each complement C3 activity assay project is scientifically appropriate, technically reliable, and aligned with customer objectives.

Complement C3 assay. (Creative Biolabs Original) Fig. 1 Workflow of complement C3 functional test.

Design Your Workflow

Why Choose Creative Biolabs?

Robust Complement Testing Platform

Creative Biolabs has developed a broad complement testing platform covering functional assays, component-specific assays, activation product analysis, inhibitor validation, pathway-specific testing, cell-based assays, and customized assay development.

Flexible Customization

Different projects require different assay strategies. Creative Biolabs provides flexible customization for sample type, species, readout, detection method, controls, data format, and reporting style.

High Sensitivity and Specificity

Our C3 activity assays are designed to provide reliable detection of C3 functional changes, activation products, deposition events, and inhibitor effects. By selecting appropriate controls, detection reagents, and optimized assay conditions, we aim to improve assay sensitivity, reduce background, and enhance data interpretation.

Multiple Technology Options

Creative Biolabs can apply ELISA, hemolysis testing, flow cytometry, fluorescence detection, cell-based assays, surface deposition assays, immunoblotting, plate-based detection, and other analytical technologies to C3 activity projects.

Applications of Complement C3 Activity Assay

Application	Descriptions
Complement Biology and Mechanism Research	C3 activity assays are widely used to investigate how complement activation is initiated, amplified, regulated, and terminated. By analyzing C3 activity under different stimulation conditions, researchers can determine whether C3 activation is driven by the classical pathway, lectin pathway, alternative pathway, or amplification loop. C3 activity data can also help identify the roles of upstream components, convertases, regulators, and effector mechanisms in specific biological systems.
Autoimmune and Inflammatory Disease Studies	In autoimmune and inflammatory disease research, C3 activity testing can reveal complement consumption, abnormal activation, autoantibody-associated dysregulation, or tissue-directed complement injury. C3 activity assays can be applied to serum, plasma, tissue extracts, disease model samples, or cell-based systems to evaluate disease mechanisms and treatment responses.
Kidney Disease and C3 Glomerulopathy Research	C3 activity assays can support studies of complement activation in glomerular injury, alternative pathway dysregulation, C3 deposition, complement consumption, and complement-targeted therapeutic intervention. Creative Biolabs can combine C3 activity testing with C3b deposition analysis, C3 fragment measurement, Factor H-related assays, Factor I-related assays, C3 convertase testing, and complement inhibitor validation to provide a comprehensive complement profile.
Complement Therapeutic Development	C3 is a high-value target in complement therapeutic development. C3 activity assays help evaluate candidate molecules that inhibit C3 cleavage, reduce C3b deposition, block amplification, regulate convertase activity, or suppress downstream inflammatory and cytolytic responses.
Infection and Immune Defense Research	C3 plays an essential role in immune defense against pathogens through opsonization and complement amplification. C3 activity assays can support research on pathogen-complement interactions, immune evasion mechanisms, serum bactericidal activity, viral immune modulation, host-pathogen recognition, and infection-related inflammation. Customized assay systems can be developed for microbial surfaces, pathogen-derived components, immune serum, or complement regulatory proteins.

Design Your Customization

Case Studies

Case 1

Complement receptor 2 based immunoassay measuring activation of the complement system at C3-level in plasma samples from mice and humans

The researchers aimed at establishing a sensitive and robust assay for estimation of systemic complement activation at complement component C3 level in mouse and human plasma samples. In order to capture the activation products iC3b and C3dg in a specific and physiological relevant manner, they utilized a construct consisting of the iC3b/C3dg-binding site of human complement receptor 2 (CR2) attached to an Fc-part of mouse IgG. This construct binds C3dg and iC3b from both mice and humans.

C3 levels were estimated by ELISA. (OA Literature) Fig. 2 Assay for human C3 fragments on EDTA samples from patients with SLE.^1,2

References

Halkjær, Lene, et al. "Complement receptor 2 based immunoassay measuring activation of the complement system at C3-level in plasma samples from mice and humans." Frontiers in Immunology 11 (2020): 774. https://doi.org/10.3389/fimmu.2020.00774
Distributed under Open Access license CC BY 4.0, without modification.

What Our Clients Say

"We were developing a complement-modulating biologic and needed a functional assay to compare several lead candidates. The Creative Biolabs team helped us design a C3 activity assay that included appropriate positive controls, inhibition controls, and dose-response analysis. The final report clearly showed which molecules had the strongest inhibitory effect on C3 activation, which helped us make an informed decision for the next development stage."

— Scientist, Biotechnology Company

"Our project involved a non-standard sample matrix, and we were concerned that a conventional assay might not provide meaningful results. Creative Biolabs discussed the experimental goal with us in detail and suggested a customized C3b deposition assay. Their team optimized the sample dilution and detection conditions before running the full study."

— Research Investigator, Immunology Laboratory

"We initially requested C3 activity testing only, but Creative Biolabs recommended combining C3 activity with C3a and C3b-related readouts to better understand complement activation in our model. This turned out to be very valuable. The integrated results allowed us to distinguish between reduced C3 protein levels, increased C3 consumption, and functional inhibition. The interpretation helped us refine our mechanism-of-action hypothesis."

— Translational Research Scientist, Pharmaceutical Company

"We needed to evaluate complement activity in preclinical serum samples collected at different time points. Creative Biolabs provided clear sample handling recommendations before shipment and helped us select an assay format compatible with the available sample volume. The turnaround was efficient, and the data presentation was suitable for internal project review."

— Project Manager, Preclinical Development Team

Frequently Asked Questions

Can Creative Biolabs measure both C3 concentration and C3 activity?

Yes. Creative Biolabs can provide both C3 concentration measurement and C3 functional activity testing. We can also measure related activation products, such as C3a, C3b, iC3b, C3d, or other complement biomarkers, depending on the project requirements. Combining C3 quantity, C3 activity, and C3 activation product analysis can provide a more complete understanding of complement status.

Is serum or plasma better for C3 activity assays?

The choice between serum and plasma depends on the assay format and research purpose. Serum is commonly used in many complement activity assays because it contains active complement components and does not include anticoagulants that may interfere with complement activation. Plasma may be preferred in certain studies when the goal is to preserve the in vivo complement status at the time of collection. However, anticoagulant selection is important because some anticoagulants can interfere with complement activity. Creative Biolabs can recommend the most suitable sample type after reviewing your project.

How much sample volume is required?

The required sample volume depends on the assay format, number of replicates, sample dilution, number of readouts, and number of test conditions. A simple single-readout assay may require a relatively small volume, while a multi-readout study involving C3 activity, C3a generation, C3b deposition, inhibitor titration, and replicates will require more sample. Creative Biolabs can provide a project-specific sample volume estimate after confirming the assay plan.

Can C3 activity testing be combined with CH50 or AH50 assays?

Yes. C3 activity testing can be combined with CH50, AH50, or other pathway activity assays. CH50 reflects classical pathway-mediated terminal complement activity, while AH50 reflects alternative pathway-mediated hemolytic activity. C3 activity testing provides component-focused information. Combining these assays can help determine whether changes in total pathway activity are associated with C3-specific functional changes, upstream pathway effects, or downstream terminal pathway changes.

Can you perform cell-based C3 activity assays?

Yes. Creative Biolabs can develop cell-based C3 activity assays using target cells, antibody-coated cells, disease-relevant cells, engineered cell lines, endothelial cells, epithelial cells, immune cells, erythrocytes, or customer-provided cells. Readouts may include C3b deposition, iC3b formation, complement-mediated cytotoxicity, cell-associated complement activation, or inhibitor-mediated protection. Flow cytometry, fluorescence detection, imaging, or plate-based detection can be used depending on the study design.

Can C3 activity assays be used for biomaterial or nanoparticle testing?

Yes. Biomaterials, nanoparticles, drug delivery vehicles, and medical device surfaces can activate complement after contact with serum or plasma. C3b deposition assays and C3 activation product assays can help evaluate complement reactivity and surface compatibility. Creative Biolabs can customize assay conditions for coated surfaces, particles, hydrogels, membranes, implants, or other materials.